Dynamic assessment of the COVID-19 vaccine acceptance leveraging social media data.

COVID-19 vaccine Natural language processing Social media Text classification Vaccine acceptance

Journal

Journal of biomedical informatics
ISSN: 1532-0480
Titre abrégé: J Biomed Inform
Pays: United States
ID NLM: 100970413

Informations de publication

Date de publication:
05 2022
Historique:
received: 26 09 2021
revised: 05 03 2022
accepted: 12 03 2022
pubmed: 26 3 2022
medline: 11 5 2022
entrez: 25 3 2022
Statut: ppublish

Résumé

Vaccination is the most effective way to provide long-lasting immunity against viral infection; thus, rapid assessment of vaccine acceptance is a pressing challenge for health authorities. Prior studies have applied survey techniques to investigate vaccine acceptance, but these may be slow and expensive. This study investigates 29 million vaccine-related tweets from August 8, 2020 to April 19, 2021 and proposes a social media-based approach that derives a vaccine acceptance index (VAI) to quantify Twitter users' opinions on COVID-19 vaccination. This index is calculated based on opinion classifications identified with the aid of natural language processing techniques and provides a quantitative metric to indicate the level of vaccine acceptance across different geographic scales in the U.S. The VAI is easily calculated from the number of positive and negative Tweets posted by a specific users and groups of users, it can be compiled for regions such a counties or states to provide geospatial information, and it can be tracked over time to assess changes in vaccine acceptance as related to trends in the media and politics. At the national level, it showed that the VAI moved from negative to positive in 2020 and maintained steady after January 2021. Through exploratory analysis of state- and county-level data, reliable assessments of VAI against subsequent vaccination rates could be made for counties with at least 30 users. The paper discusses information characteristics that enable consistent estimation of VAI. The findings support the use of social media to understand opinions and to offer a timely and cost-effective way to assess vaccine acceptance.

Identifiants

pubmed: 35331966
pii: S1532-0464(22)00070-3
doi: 10.1016/j.jbi.2022.104054
pmc: PMC8935963
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104054

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

Vaccine. 2020 Jan 22;38(4):709-711
pubmed: 31836257
Nature. 2020 Jun;582(7811):230-233
pubmed: 32499650
Vaccine. 2020 Mar 17;38(13):2764-2770
pubmed: 32093982
Vaccine. 2021 Jan 8;39(2):350-356
pubmed: 33280856
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Hum Vaccin Immunother. 2021 Jul 3;17(7):2018-2025
pubmed: 33369524
Vaccine. 2018 Nov 26;36(49):7556-7561
pubmed: 30389192
Vaccine. 2017 Jun 22;35(29):3621-3638
pubmed: 28554500
Acad Pediatr. 2016 Jan-Feb;16(1):42-9
pubmed: 26300368
Vaccine. 2018 Jan 29;36(5):660-667
pubmed: 29289384
Vaccine. 2019 Oct 8;37(43):6317-6323
pubmed: 31521412
Vaccine. 2020 Sep 29;38(42):6627-6637
pubmed: 32788136
Vaccine. 2018 Feb 1;36(6):779-787
pubmed: 29325822
Intell Med. 2022 Feb;2(1):1-12
pubmed: 34457371
Vaccine. 2021 Feb 12;39(7):1148-1156
pubmed: 33461834
Vaccine. 2014 Oct 29;32(47):6259-65
pubmed: 25258098
Vaccine. 2019 Feb 4;37(6):848-856
pubmed: 30642731
Am J Transplant. 2021 Apr;21(4):1650-1656
pubmed: 33788992
Hum Vaccin Immunother. 2021 Oct 3;17(10):3262-3267
pubmed: 34170793
Vaccine. 2020 Sep 11;38(40):6236-6247
pubmed: 32792251
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Vaccines (Basel). 2021 Jan 07;9(1):
pubmed: 33430428
Soc Sci Med. 2019 Nov;240:112552
pubmed: 31561111
Hum Vaccin. 2011 Apr;7(4):419-25
pubmed: 21389777
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384
Prev Med. 2018 Apr;109:1-7
pubmed: 29337069
Prev Med. 2020 Sep;138:106151
pubmed: 32473273
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Annu Rev Public Health. 2021 Apr 1;42:175-191
pubmed: 33798403
JAMA. 2021 Jun 15;325(23):2397-2399
pubmed: 34028495

Auteurs

Lingyao Li (L)

Department of Civil and Environmental Engineering, A. James Clark School of Engineering, University of Maryland, College Park, MD, USA. Electronic address: lli12316@umd.edu.

Jiayan Zhou (J)

Department of Veterinary and Biomedical Sciences, College of Agricultural Sciences, The Pennsylvania State University, University Park, PA, USA; Department of Statistics, Eberly College of Science, The Pennsylvania State University, University Park, PA, USA. Electronic address: jpz5091@psu.edu.

Zihui Ma (Z)

Department of Civil and Environmental Engineering, A. James Clark School of Engineering, University of Maryland, College Park, MD, USA. Electronic address: zma88@terpmail.umd.edu.

Michelle T Bensi (MT)

Department of Civil and Environmental Engineering, A. James Clark School of Engineering, University of Maryland, College Park, MD, USA. Electronic address: mbensi@umd.edu.

Molly A Hall (MA)

Department of Veterinary and Biomedical Sciences, College of Agricultural Sciences, The Pennsylvania State University, University Park, PA, USA; The Huck Institutes of the Life Science, The Pennsylvania State University, University Park, PA, USA; Penn State Cancer Institute, The Pennsylvania State University, University Park, PA, USA. Electronic address: mah546@psu.edu.

Gregory B Baecher (GB)

Department of Civil and Environmental Engineering, A. James Clark School of Engineering, University of Maryland, College Park, MD, USA. Electronic address: gbaecher@umd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH